Marseille Cedex 09, France Clinical Trials

A listing of Marseille Cedex 09, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 569 clinical trials
featured
Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2).

This study is a Phase 3 global, multicenter, placebo-controlled double-blind randomized study that will enroll participants with inoperable locally recurrent or metastatic SCAC not previously treated with systemic chemotherapy.

Institut du Cancer de Montpellier
 (80.2 away) Contact site
  • 6 views
  • 29 Jul, 2021
  • +83 other locations
A Study of TAK-788 in Adults With Non-Small Cell Lung Cancer

This study is about a medicine called TAK-788, also known as mobocertinib, given to adults with non-small cell lung cancer. The main aims of this study are to check if there are any side effects from TAK-788, to learn how TAK-788 is processed by the body, and to determine the …

cancer chemotherapy
erbb2
pemetrexed
measurable disease
systemic therapy
Hopital de la Timone
 (1.4 away) Contact site
  • 0 views
  • 31 May, 2021
  • +97 other locations
Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors

This is a phase 1 study to evaluate the safety of intralesional talimogene laherparepvec administration in pediatric subjects with advanced non-CNS tumors that are amenable to direct injection

Research Site
 (1.7 away) Contact site
  • 0 views
  • 20 Jun, 2021
  • +44 other locations
Study of REGN2810 in Patients With Advanced Cutaneous Squamous Cell Carcinoma

For Groups 1 to 4, the primary objective of this study is to estimate the clinical benefit of cemiplimab monotherapy for patients with: metastatic (nodal or distant) cutaneous squamous cell carcinoma (CSCC), or unresectable locally advanced CSCC. For Group 6, the primary objective is to provide additional efficacy and safety …

Hopitaux de La Timone
 (6.0 away) Contact site
  • 0 views
  • 28 Jan, 2021
  • +102 other locations
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)

This is a prospective, multicenter, open-label, randomized, controlled, parallel group, group-sequential, event-driven Phase 3 study to evaluate efficacy, safety and pharmacokinetics (PK) of macitentan in children.

macitentan
hypertension
heart disease
connective tissue disease
H pital Des Enfants
 (197.3 away) Contact site
  • 172 views
  • 16 Jun, 2021
  • +106 other locations
Study of the Effect of the Benfluorex

More than 5 million persons in France exposed, in last years, to the taking of the Benfluorex. Arisen, at certain patients, of a valvulopathy characterized by mitrals and/or aortic leaks Withdrawal of the French market: nov. 2009 Only a percentage limited by exposed patients developed a severe valvulopathy (1/1000), whereas …

H pital Saint Philibert
 (111.6 away) Contact site
  • 0 views
  • 26 Jan, 2021
  • +11 other locations
Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: My Own Specific Treatment

The MOST Plus study is a two-period phase II clinical trial, conducted in patients with all types of progressive solid tumors after at least 1 prior systemic treatment regimen for advanced disease (in the absence of a validated second line therapy). The main goal of this study is to evaluate …

Institut Curie
 (29.5 away) Contact site
  • 0 views
  • 11 Feb, 2021
  • +11 other locations
Axillary Node Dissection Versus no Dissection in Breast Cancer With Positive Sentinel Lymph Node

Data from cohorts, prospective studies and one randomized trial (ASCOG Z0011) support the hypothesis that omission of additional axillary dissection in case of positive sentinel node has a limited impact on overall survival and relapse free survival. However, these data are not sufficient enough to recommend, as a standard of …

endocrine therapy
sentinel node
tumor cells
metastasis
hormone therapy
Gilles HOUVENAEGHEL, PHD
 (6.0 away) Contact site
  • 0 views
  • 24 Jan, 2021
  • 1 location
Familial Dysglobulinemia

Multiple Myeloma (MM) is a malignant proliferation of monoclonal plasma cells. Myeloma accounts for almost 14% of all hematologic cancers and is essentially incurable. Myeloma commonly evolves from a precursor disease, Monoclonal gammopathy of undetermined significance (MGUS). Despite intensive study, the etiology of MGUS and myeloma are unknown and no …

Institut Curie
 (29.5 away) Contact site
  • 26 views
  • 25 Jan, 2021
  • +46 other locations
An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma

The overall aim of this project is to improve the outcome of patients diagnosed with ependymoma by improving and harmonising the staging and the standard of care of this patient population and to improve the investigators understanding of the underlying biology thereby informing future treatment. The program will evaluate new …

CHRU MONTPELLIER - H pital Arnaud de Villeneuve
 (77.7 away) Contact site
  • 25 views
  • 24 Jan, 2021
  • +61 other locations